ANRIL: molecular mechanisms and implications in human health

review OA: gold CC-BY-4.0 ⤵ 1 in-corpus citation
📄 Open PDF View on PubMed View at publisher

Abstract

ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions. ANRIL has been shown to regulate its neighbor tumor suppressors CDKN2A/B by epigenetic mechanisms and thereby regulate cell proliferation and senescence. However, the clear role of ANRIL in the pathogenesis of these conditions is yet to be understood. Here, we review the recent findings on ANRIL molecular characterization and function, with a particular focus on its implications in human disease.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Chromosomes, Human, Pair 9 Genetic Predisposition to Disease Polymorphism, Single Nucleotide RNA, Long Noncoding Chromosomes, Human, Pair 9 Cyclin-Dependent Kinase Inhibitor p15 Cyclin-Dependent Kinase Inhibitor p15 Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p16 Gene Expression Regulation Genetic Predisposition to Disease Humans Models, Genetic Purine-Nucleoside Phosphorylase Purine-Nucleoside Phosphorylase RNA, Long Noncoding

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-18T06:15:08.409253+00:00
pubmed
last seen: 2026-05-13T22:19:12.052662+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine